Bereich
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin
AIM · Dept. I
Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
Pollock R, Valentine W, Goodall G, Brändle M. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents. Swiss Med Wkly 2010; 140:w13103.
25.10.2010Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
25.10.2010Swiss Med Wkly 2010; 140:w13103
Pollock Richard F, Valentine William J, Goodall Gordon, Brändle Michael
Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome
Möller-Goede D, Brändle M, Landau K, Bernays R, Schmid C. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 2010; 164:37-43.
06.10.2010Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome
06.10.2010Eur J Endocrinol 2010; 164:37-43
Möller-Goede Diane L, Brändle Michael, Landau Klara, Bernays René L, Schmid Christoph
Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery
Steffen T, Warschkow R, Brändle M, Tarantino I, Clerici T. Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery. Br J Surg 2010; 97:1000-6.
01.07.2010Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery
01.07.2010Br J Surg 2010; 97:1000-6
Steffen Thomas, Warschkow Rene, Brändle Michael, Tarantino Ignazio, Clerici Thomas
Das St. Galler Projekt: Vom Projekt zum Modell?
Häuptle C, Meyenberger C, Greminger P. Das St. Galler Projekt: Vom Projekt zum Modell? - Weiterbildung in Hausarztmedizin und Implementierung der Hausarztmedizin. Schweizerische Ärztezeitung 2010; 91:949-953.
18.06.2010Das St. Galler Projekt: Vom Projekt zum Modell?
18.06.2010Schweizerische Ärztezeitung 2010; 91:949-953
Häuptle Christian, Meyenberger Christa, Greminger Peter
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
Böhm S, Hess D, Gillessen Sommer S, Brändle M. Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib. Diabetes care 2010; 33:e82.
01.06.2010Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
01.06.2010Diabetes care 2010; 33:e82
Böhm Steffen, Hess Dagmar, Gillessen Sommer Silke, Brändle Michael
Spontaneous normothermia compared to mild therapeutic hypothermia in patients after cardiac arrest
Hörburger D, Testori C, Sterz F, Anton L, Holzer M (2010). Spontaneous normothermia compared to mild therapeutic hypothermia in patients after cardiac arrest.
02.04.2010Spontaneous normothermia compared to mild therapeutic hypothermia in patients after cardiac arrest
02.04.2010European Resuscitation Council (ERC) Congress 2010
Hörburger David, Testori Christoph, Sterz Fritz, Anton Laggner, Holzer Michael
Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome
Krull I, Maier M, Bärlocher K, Koehler K, Huebner A, Brändle M. Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome. Exp Clin Endocrinol Diabetes 2010; 118:530-6.
03.03.2010Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome
03.03.2010Exp Clin Endocrinol Diabetes 2010; 118:530-6
Krull Ina, Maier Margarete, Bärlocher K, Koehler K, Huebner A, Brändle Michael
Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
Brändle M. Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie - Contra - eine kritische Beurteilung. Swiss Medical Forum 2010; 10:88-91.
04.02.2010Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
04.02.2010Swiss Medical Forum 2010; 10:88-91
Brändle Michael
Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
Schimke K, Greminger P, Brändle M. Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51.
01.11.2009Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
01.11.2009Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51
Schimke Katrin-Elisabeth, Greminger Peter, Brändle Michael
Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Christ E, Maecke H, Martius F, Gloor B, Clerici T, Sahli R, Brändle M, Forrer F, Wild D, Reubi J. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. The Journal of clinical endocrinology and metabolism 2009; 94:4398-405.
01.11.2009Glucagon-like peptide-1 receptor imaging for localization of insulinomas
01.11.2009The Journal of clinical endocrinology and metabolism 2009; 94:4398-405
Christ Emanuel, Maecke Helmut, Martius Ferdinand, Gloor Beat, Clerici Thomas, Sahli Rahel, Brändle Michael, Forrer Flavio, Wild Damian, Reubi Jean Claude
[New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]
Lehmann R, Troendle A, Brändle M, Schweizerischen Gesellschaft für Endokrinologie und Diabetologie. [New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]. Therapeutische Umschau. Revue thérapeutique 2009; 66:695-706.
01.10.2009[New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]
01.10.2009Therapeutische Umschau. Revue thérapeutique 2009; 66:695-706
Lehmann Roger, Troendle A, Brändle Michael, Schweizerischen Gesellschaft für Endokrinologie und Diabetologie
Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
Brändle M, Erny-Albrecht K, Goodall G, Spinas G, Streit P, Valentine W. Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland. International journal of clinical pharmacology and therapeutics 2009; 47:501-15.
01.08.2009Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
01.08.2009International journal of clinical pharmacology and therapeutics 2009; 47:501-15
Brändle Michael, Erny-Albrecht K M, Goodall G, Spinas G A, Streit P, Valentine W J
Rettungsdienstliche Leistungen bei Großveranstaltungen
Hörburger D, Anton L. Rettungsdienstliche Leistungen bei Großveranstaltungen. Intensivmedizin und Notfallmedizin 2009; 47:130-134.
20.06.2009Rettungsdienstliche Leistungen bei Großveranstaltungen
20.06.2009Intensivmedizin und Notfallmedizin 2009; 47:130-134
Hörburger David, Anton Laggner
Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism
Goede D, Wiesli P, Brändle M, Bestmann L, Bernays R, Zwimpfer C, Schmid C. Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:339-44.
13.06.2009Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism
13.06.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:339-44
Goede Diane L, Wiesli Peter, Brändle Michael, Bestmann Lukas, Bernays René L, Zwimpfer Cornelia, Schmid Christoph
New onset alopecia and hirsutism in a postmenopausal women
Bühler-Christen A, Tischler V, Diener P, Brändle M. New onset alopecia and hirsutism in a postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009; 25:324-7.
01.05.2009New onset alopecia and hirsutism in a postmenopausal women
01.05.2009Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009; 25:324-7
Bühler-Christen Annette, Tischler Verena, Diener Pierre-André, Brändle Michael
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
Brändle M, Goodall G, Erny-Albrecht K, Erdmann E, Valentine W. Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:173-84.
21.03.2009Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
21.03.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:173-84
Brändle Michael, Goodall G, Erny-Albrecht K M, Erdmann E, Valentine W J
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
Marre M, Colagiuri S, Le Thi T, Zdravkovic M, Strand J, Kamaruddin N, Bebakar W, Brändle M, Shaw J, LEAD-1 SU study group. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic medicine : a journal of the British Diabetic Association 2009; 26:268-78.
01.03.2009Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
01.03.2009Diabetic medicine : a journal of the British Diabetic Association 2009; 26:268-78
Marre M, Colagiuri S, Le Thi T D, Zdravkovic M, Strand J, Kamaruddin N A, Bebakar W M W, Brändle Michael, Shaw J, LEAD-1 SU study group
Myokardinfarkt bei Suizidversuch
Tapernoux D, Weilenmann D, Diethelm M. Myokardinfarkt bei Suizidversuch. Deutsche medizinische Wochenschrift (1946) 2009; 134:339-342.
16.02.2009Myokardinfarkt bei Suizidversuch
16.02.2009Deutsche medizinische Wochenschrift (1946) 2009; 134:339-342
Tapernoux Daniel, Weilenmann Daniel, Diethelm Markus
Die Achillesferse der COPD-Behandlung
Tapernoux D, Weilenmann D, Diethelm M. Die Achillesferse der COPD-Behandlung - Myocardial infarction during attempted suicide. Deutsche medizinische Wochenschrift (1946) 2009; 134:339-42.
01.02.2009Die Achillesferse der COPD-Behandlung
01.02.2009Deutsche medizinische Wochenschrift (1946) 2009; 134:339-42
Tapernoux Daniel, Weilenmann Daniel, Diethelm Markus
Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus
Phillippe J, Weissenberger B, Stahl M, Ruiz J, Kuntschen F, Keller U, Diem P, Carrel J, Brändle M, Spinas G. Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus - Consensus Statement der Schweizerischen Gesellschaft für Endokrinologie. Swiss Medical Forum 2009; 9:50-55.
22.01.2009Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus
22.01.2009Swiss Medical Forum 2009; 9:50-55
Phillippe Jacques, Weissenberger Benno, Stahl Matthias, Ruiz Juan, Kuntschen François, Keller Ulrich, Diem Peter, Carrel Jacques, Brändle Michael, Spinas Giatgen A